{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T14:00:49Z","timestamp":1765807249201},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2015,5,14]],"date-time":"2015-05-14T00:00:00Z","timestamp":1431561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,5,14]],"date-time":"2015-05-14T00:00:00Z","timestamp":1431561600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cancer-initiating cell (CIC) is critical in cancer development, maintenance and recurrence. The reverse expression pattern of coxsackie and adenovirus receptor (CAR) and <jats:italic>\u03b1<\/jats:italic><jats:sub><jats:italic>\u03bd<\/jats:italic><\/jats:sub> integrin in bladder cancer decreases the infection efficiency of adenovirus. We constructed Arg-Gly-Asp (RGD)-modified oncolytic adenovirus, carrying EGFP or TNF-related apoptosis-inducing ligand (TRAIL) gene (Onco<jats:sup>Ad<\/jats:sup>.RGD-hTERT-EGFP\/TRAIL), and applied them to CAR-negative bladder cancer T24 cells and cancer-initiating T24 sphere cells. Onco<jats:sup>Ad<\/jats:sup>.RGD-hTERT-EGFP had enhanced infection ability and cytotoxic effect on T24 cells and T24 sphere cells, but little cytoxicity on normal urothelial SV-HUC-1 cells compared with the unmodified virus Onco<jats:sup>Ad<\/jats:sup>.hTERT-EGFP. Notably, Onco<jats:sup>Ad<\/jats:sup>.RGD-hTERT-TRAIL induced apoptosis in T24 cells and T24 sphere cells. Furthermore, it completely inhibited xenograft initiation established by the oncolytic adenovirus-pretreated T24 sphere cells, and significantly suppressed tumor growth by intratumoral injection. These results provided a promising therapeutic strategy for CAR-negative bladder cancer through targeting CICs.<\/jats:p>","DOI":"10.1038\/cddis.2015.128","type":"journal-article","created":{"date-parts":[[2015,5,14]],"date-time":"2015-05-14T12:52:03Z","timestamp":1431607923000},"page":"e1760-e1760","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["RGD-modifided oncolytic adenovirus exhibited potent cytotoxic effect on CAR-negative bladder cancer-initiating cells"],"prefix":"10.1038","volume":"6","author":[{"given":"Y","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X-Y","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,5,14]]},"reference":[{"key":"BFcddis2015128_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3322\/caac.21208","volume":"64","author":"R Siegel","year":"2014","unstructured":"Siegel R, Ma JM, Zou ZH, Jemal A . Cancer Statistics, 2014. CA Cancer J Clin 2014; 64: 9\u201329.","journal-title":"CA Cancer J Clin"},{"key":"BFcddis2015128_CR2","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1097\/00042307-200007000-00002","volume":"10","author":"W Hassen","year":"2000","unstructured":"Hassen W, Droller MJ . Current concepts in assessment and treatment of bladder cancer. Curr Opin Urol 2000; 10: 291\u2013299.","journal-title":"Curr Opin Urol"},{"key":"BFcddis2015128_CR3","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1056\/NEJM199411103311903","volume":"331","author":"D Esrig","year":"1994","unstructured":"Esrig D, Elmajian D, Groshen S, Freeman JA, Stein JP, Chen SC et al. Accumulation of nuclear p53 and tumor progression in bladder cancer. N Engl J Med 1994; 331: 1259\u20131264.","journal-title":"N Engl J Med"},{"key":"BFcddis2015128_CR4","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/385123b0","volume":"385","author":"RJ Cote","year":"1997","unstructured":"Cote RJ, Esrig D, Groshen S, Jones PA, Skinner DG . p53 and treatment of bladder cancer. Nature 1997; 385: 123\u2013125.","journal-title":"Nature"},{"key":"BFcddis2015128_CR5","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1038\/sj.onc.1202452","volume":"18","author":"WF Benedict","year":"1999","unstructured":"Benedict WF, Lerner SP, Zhou J, Shen X, Tokunaga H, Czerniak B . Level of retinoblastoma protein expression correlates with p16 (MTS-1\/INK4A\/CDKN2) status in bladder cancer. Oncogene 1999; 18: 1197\u20131203.","journal-title":"Oncogene"},{"key":"BFcddis2015128_CR6","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.urology.2005.02.033","volume":"66","author":"K Matsumoto","year":"2005","unstructured":"Matsumoto K, Shariat SF, Ayala GE, Rauen KA, Lerner SP . Loss of coxsackie and adenovirus receptor expression is associated with features of aggressive bladder cancer. Urology 2005; 66: 441\u2013446.","journal-title":"Urology"},{"key":"BFcddis2015128_CR7","first-page":"6592","volume":"61","author":"T Okegawa","year":"2001","unstructured":"Okegawa T, Pong RC, Li Y, Bergelson JM, Sagalowsky AI, Hsieh JT . The mechanism of the growth-inhibitory effect of coxsackie and adenovirus receptor (CAR) on human bladder cancer: a functional analysis of car protein structure. Cancer Res 2001; 61: 6592\u20136600.","journal-title":"Cancer Res"},{"key":"BFcddis2015128_CR8","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/S0090-4295(02)01748-X","volume":"60","author":"MD Sachs","year":"2002","unstructured":"Sachs MD, Rauen KA, Ramamurthy M, Dodson JL, De Marzo AM, Putzi MJ et al. Integrin alpha(v) and coxsackie adenovirus receptor expression in clinical bladder cancer. Urology 2002; 60: 531\u2013536.","journal-title":"Urology"},{"key":"BFcddis2015128_CR9","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/nrd2137","volume":"8","author":"BB Zhou","year":"2009","unstructured":"Zhou BB, Zhang H, Damelin M, Geles KG, Grindley JC, Dirks PB . Tumour-initiating cells: challenges and opportunities for anticancer drug discovery. Nat Rev Drug Discov 2009; 8: 806\u2013823.","journal-title":"Nat Rev Drug Discov"},{"key":"BFcddis2015128_CR10","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/367645a0","volume":"367","author":"T Lapidot","year":"1994","unstructured":"Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres-Cortes J et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 1994; 367: 645\u2013648.","journal-title":"Nature"},{"key":"BFcddis2015128_CR11","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/nm0797-730","volume":"3","author":"D Bonnet","year":"1997","unstructured":"Bonnet D, Dick JE . Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997; 3: 730\u2013737.","journal-title":"Nat Med"},{"key":"BFcddis2015128_CR12","doi-asserted-by":"publisher","first-page":"6890","DOI":"10.1073\/pnas.0530291100","volume":"100","author":"M Al-Hajj","year":"2003","unstructured":"Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF . Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003; 100: 6890\u20136890.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcddis2015128_CR13","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1080\/07357900801941845","volume":"26","author":"YM Yang","year":"2008","unstructured":"Yang YM, Chang JW . Bladder cancer initiating cells (BCICs) are among EMA-CD44v6+ subset: novel methods for isolating undetermined cancer stem (initiating) cells. Cancer Invest 2008; 26: 725\u2013733.","journal-title":"Cancer Invest"},{"key":"BFcddis2015128_CR14","first-page":"733","volume":"32","author":"MJ Falso","year":"2012","unstructured":"Falso MJ, Buchholz BA, White RW . Stem-like cells in bladder cancer cell lines with differential sensitivity to cisplatin. Anticancer Res 2012; 32: 733\u2013738.","journal-title":"Anticancer Res"},{"key":"BFcddis2015128_CR15","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1016\/j.bbadis.2014.07.007","volume":"1842","author":"R Ojha","year":"2014","unstructured":"Ojha R, Jha V, Singh SK, Bhattacharyya S . Autophagy inhibition suppresses the tumorigenic potential of cancer stem cell enriched side population in bladder cancer. Biochim Biophys Acta 2014; 1842: 2073\u20132086.","journal-title":"Biochim Biophys Acta"},{"key":"BFcddis2015128_CR16","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/B978-0-12-397833-2.00002-9","volume-title":"Recent Advances in Cancer Research and Therapy","author":"L Xin-Yuan","year":"2012","unstructured":"Xin-Yuan L, Huang W-L, Qian Q-J, Zou W-G, Zhang Z-L, Chu L et al. 2 - Cancer targeting gene\u2013viro\u2013therapy and its promising future: A trend in both cancer gene therapy and cancer virotherapy. In: Shi X-YLP-F (ed), Recent Advances in Cancer Research and Therapy. Elsevier: : Oxford, 2012 pp 33\u201383."},{"key":"BFcddis2015128_CR17","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1038\/sj.cr.7310108","volume":"16","author":"XY Liu","year":"2006","unstructured":"Liu XY . Targeting gene-virotherapy of cancer and its prosperity. Cell Res 2006; 16: 879\u2013886.","journal-title":"Cell Res"},{"key":"BFcddis2015128_CR18","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1002\/hep.20203","volume":"39","author":"Z Pei","year":"2004","unstructured":"Pei Z, Chu L, Zou W, Zhang Z, Qiu S, Qi R et al. An oncolytic adenoviral vector of Smac increases antitumor activity of TRAIL against HCC in human cells and in mice. Hepatology 2004; 39: 1371\u20131381.","journal-title":"Hepatology"},{"key":"BFcddis2015128_CR19","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1038\/sj.cgt.7700969","volume":"13","author":"L Zhao","year":"2006","unstructured":"Zhao L, Dong A, Gu J, Liu Z, Zhang Y, Zhang W et al. The antitumor activity of TRAIL and IL-24 with replicating oncolytic adenovirus in colorectal cancer. Cancer Gene Ther 2006; 13: 1011\u20131022.","journal-title":"Cancer Gene Ther"},{"key":"BFcddis2015128_CR20","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1186\/1471-2407-14-668","volume":"14","author":"HN Xu","year":"2014","unstructured":"Xu HN, Shen ZX, Xiao J, Yang Y, Huang WD, Zhou ZM et al. Acetylcholinesterase overexpression mediated by oncolytic adenovirus exhibited potent anti-tumor effect. BMC Cancer 2014; 14: 668.","journal-title":"BMC Cancer"},{"key":"BFcddis2015128_CR21","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.1158\/1078-0432.CCR-07-1528","volume":"14","author":"X Zhang","year":"2008","unstructured":"Zhang X, Komaki R, Wang L, Fang B, Chang JY . Treatment of radioresistant stem-like esophageal cancer cells by an apoptotic gene-armed, telomerase-specific oncolytic adenovirus. Clin Cancer Res 2008; 14: 2813\u20132823.","journal-title":"Clin Cancer Res"},{"key":"BFcddis2015128_CR22","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1038\/sj.bjc.6605952","volume":"103","author":"MR Loebinger","year":"2010","unstructured":"Loebinger MR, Sage EK, Davies D, Janes SM . TRAIL-expressing mesenchymal stem cells kill the putative cancer stem cell population. Br J Cancer 2010; 103: 1692\u20131697.","journal-title":"Br J Cancer"},{"key":"BFcddis2015128_CR23","volume-title":"Fields Virology, vol. 2","author":"AJ Berk","year":"2007","unstructured":"Berk AJ . Fields Virology, vol. 2. Lippincott Williams & Wilkins: : Philadelphia, 2007."},{"key":"BFcddis2015128_CR24","doi-asserted-by":"publisher","first-page":"e513","DOI":"10.1016\/j.urology.2013.10.048","volume":"83","author":"H Wang","year":"2014","unstructured":"Wang H, Cai Z, Yang F, Luo J, Satoh M, Arai Y et al. Enhanced antitumor efficacy of integrin-targeted oncolytic adenovirus AxdAdB3-F\/RGD on bladder cancer. Urology 2014; 83: e513\u2013509.","journal-title":"Urology"},{"key":"BFcddis2015128_CR25","first-page":"325","volume":"59","author":"Y Li","year":"1999","unstructured":"Li Y, Pong RC, Bergelson JM, Hall MC, Sagalowsky AI, Tseng CP et al. Loss of adenoviral receptor expression in human bladder cancer cells: a potential impact on the efficacy of gene therapy. Cancer Res 1999; 59: 325\u2013330.","journal-title":"Cancer Res"},{"key":"BFcddis2015128_CR26","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1128\/JVI.72.3.1844-1852.1998","volume":"72","author":"V Krasnykh","year":"1998","unstructured":"Krasnykh V, Dmitriev I, Mikheeva G, Miller CR, Belousova N, Curiel DT . Characterization of an adenovirus vector containing a heterologous peptide epitope in the HI loop of the fiber knob. J Virol 1998; 72: 1844\u20131852.","journal-title":"J Virol"},{"key":"BFcddis2015128_CR27","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1093\/jnci\/djm102","volume":"99","author":"H Jiang","year":"2007","unstructured":"Jiang H, Gomez-Manzano C, Aoki H, Alonso MM, Kondo S, McCormick F et al. Examination of the therapeutic potential of Delta-24-RGD in brain tumor stem cells: role of autophagic cell death. J Natl Cancer Inst 2007; 99: 1410\u20131414.","journal-title":"J Natl Cancer Inst"},{"key":"BFcddis2015128_CR28","first-page":"7936","volume":"63","author":"NA Lanson Jr.","year":"2003","unstructured":"Lanson NA Jr., Friedlander PL, Schwarzenberger P, Kolls JK, Wang G . Replication of an adenoviral vector controlled by the human telomerase reverse transcriptase promoter causes tumor-selective tumor lysis. Cancer Res 2003; 63: 7936\u20137941.","journal-title":"Cancer Res"},{"key":"BFcddis2015128_CR29","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1478-811X-8-6","volume":"8","author":"Y Welte","year":"2010","unstructured":"Welte Y, Adjaye J, Lehrach HR, Regenbrecht CRA . Cancer stem cells in solid tumors: elusive or illusive? Cell Commun Signal 2010; 8: 6.","journal-title":"Cell Commun Signal"},{"key":"BFcddis2015128_CR30","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/sj.cgt.7700806","volume":"12","author":"AV Borovjagin","year":"2005","unstructured":"Borovjagin AV, Krendelchtchikov A, Ramesh N, Yu DC, Douglas JT, Curiel DT . Complex mosaicism is a novel approach to infectivity enhancement of adenovirus type 5-based vectors. Cancer Gene Ther 2005; 12: 475\u2013486.","journal-title":"Cancer Gene Ther"},{"key":"BFcddis2015128_CR31","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.1158\/1078-0432.CCR-06-2103","volume":"13","author":"M Wakayama","year":"2007","unstructured":"Wakayama M, Abei M, Kawashima R, Seo E, Fukuda K, Ugai H et al. E1A, E1B double-restricted adenovirus with RGD-fiber modification exhibits enhanced oncolysis for CAR-deficient biliary cancers. Clin Cancer Res 2007; 13: 3043\u20133050.","journal-title":"Clin Cancer Res"},{"key":"BFcddis2015128_CR32","first-page":"3137","volume":"32","author":"K Hiwasa","year":"2012","unstructured":"Hiwasa K, Nagaya H, Terao S, Acharya B, Hamada K, Mizuguchi H et al. Improved gene transfer into bladder cancer cells using adenovirus vector containing RGD motif. Anticancer Res 2012; 32: 3137\u20133140.","journal-title":"Anticancer Res"},{"key":"BFcddis2015128_CR33","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/mt.2009.262","volume":"18","author":"J Nemunaitis","year":"2010","unstructured":"Nemunaitis J, Tong AW, Nemunaitis M, Senzer N, Phadke AP, Bedell C et al. A phase I study of telomerase-specific replication competent oncolytic adenovirus (telomelysin) for various solid tumors. Mol Ther 2010; 18: 429\u2013434.","journal-title":"Mol Ther"},{"key":"BFcddis2015128_CR34","first-page":"5415","volume":"19","author":"A Singh","year":"1999","unstructured":"Singh A, Jones RF, Friedman H, Hathir S, Soos G, Zabo A et al. Expression of p53 and pRb in bladder and prostate cancers of patients having both cancers. Anticancer Res 1999; 19: 5415\u20135417.","journal-title":"Anticancer Res"},{"key":"BFcddis2015128_CR35","doi-asserted-by":"publisher","first-page":"10879","DOI":"10.1007\/s13277-014-2353-7","volume":"35","author":"L Wang","year":"2014","unstructured":"Wang L, Zhang Y, Zhao J, Xiao E, Lu J, Fu S et al. Combination of bladder cancer-specific oncolytic adenovirus gene therapy with cisplatin on bladder cancer in vitro. Tumour Biol 2014; 35: 10879\u201310890.","journal-title":"Tumour Biol"},{"key":"BFcddis2015128_CR36","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.urolonc.2005.11.028","volume":"24","author":"JJ Melquist","year":"2006","unstructured":"Melquist JJ, Kacka M, Li YM, Malaeb BS, Elmore J, Baseman AG et al. Conditionally replicating adenovirus-mediated gene therapy in bladder cancer: An orthotopic in vivo model. Urol Oncol 2006; 24: 362\u2013371.","journal-title":"Urol Oncol"},{"key":"BFcddis2015128_CR37","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1054\/bjoc.2000.1641","volume":"84","author":"C Fujiyama","year":"2001","unstructured":"Fujiyama C, Jones A, Fuggle S, Bicknell R, Cranston D, Harris AL . Human bladder cancer invasion model using rat bladder in vitro and its use to test mechanisms and therapeutic inhibitors of invasion. Br J Cancer 2001; 84: 558\u2013564.","journal-title":"Br J Cancer"},{"key":"BFcddis2015128_CR38","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.7314\/APJCP.2014.15.5.2013","volume":"15","author":"H Keymoosi","year":"2014","unstructured":"Keymoosi H, Gheytanchi E, Asgari M, Shariftabrizi A, Madjd Z . ALDH1 in combination with CD44 as putative cancer stem cell markers are correlated with poor prognosis in urothelial carcinoma of the urinary bladder. Asian Pac J Cancer Prev 2014; 15: 2013\u20132020.","journal-title":"Asian Pac J Cancer Prev"},{"key":"BFcddis2015128_CR39","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1159\/000261073","volume":"30","author":"YR Na","year":"2009","unstructured":"Na YR, Seok SH, Kim DJ, Han JH, Kim TH, Jung H et al. Isolation and characterization of spheroid cells from human malignant melanoma cell line WM-266-4. Tumor Biol 2009; 30: 300\u2013309.","journal-title":"Tumor Biol"},{"key":"BFcddis2015128_CR40","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/nrurol.2012.142","volume":"9","author":"PL Ho","year":"2012","unstructured":"Ho PL, Kurtova A, Chan KS . Normal and neoplastic urothelial stem cells: getting to the root of the problem. Nat Rev Urol 2012; 9: 583\u2013594.","journal-title":"Nat Rev Urol"},{"key":"BFcddis2015128_CR41","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1080\/07357900801941845","volume":"26","author":"YM Yang","year":"2008","unstructured":"Yang YM, Chang JW . Bladder cancer initiating cells (BCICs) are among EMA(-)CD44v6(+) subset: Novel methods for isolating undetermined cancer stem (initiating) cells. Cancer Investig 2008; 26: 725\u2013733.","journal-title":"Cancer Investig"},{"key":"BFcddis2015128_CR42","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/ncb2956","volume":"16","author":"K Shin","year":"2014","unstructured":"Shin K, Lim A, Odegaard JI, Honeycutt JD, Kawano S, Hsieh MH et al. Cellular origin of bladder neoplasia and tissue dynamics of its progression to invasive carcinoma. Nat Cell Biol 2014; 16: 469\u2013U194.","journal-title":"Nat Cell Biol"},{"key":"BFcddis2015128_CR43","first-page":"733","volume":"32","author":"MJS Falso","year":"2012","unstructured":"Falso MJS, Buchholz BA, White RWD . Stem-like cells in bladder cancer cell lines with differential sensitivity to cisplatin. Anticancer Res 2012; 32: 733\u2013738.","journal-title":"Anticancer Res"},{"key":"BFcddis2015128_CR44","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1016\/j.juro.2010.01.064","volume":"183","author":"T Klatte","year":"2010","unstructured":"Klatte T, Seligson DB, Rao JY, Yu H, de Martino M, Garraway I et al. Absent CD44v6 expression is an independent predictor of poor urothelial bladder cancer outcome. J Urol 2010; 183: 2403\u20132408.","journal-title":"J Urol"},{"key":"BFcddis2015128_CR45","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nrc1590","volume":"5","author":"M Dean","year":"2005","unstructured":"Dean M, Fojo T, Bates S . Tumour stem cells and drug resistance. Nat Rev Cancer 2005; 5: 275\u2013284.","journal-title":"Nat Rev Cancer"},{"key":"BFcddis2015128_CR46","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1158\/1535-7163.MCT-09-0367","volume":"8","author":"JJ Short","year":"2009","unstructured":"Short JJ, Curiel DT . Oncolytic adenoviruses targeted to cancer stem cells. Mol Cancer Ther 2009; 8: 2096\u20132102.","journal-title":"Mol Cancer Ther"},{"key":"BFcddis2015128_CR47","doi-asserted-by":"crossref","first-page":"5615","DOI":"10.18632\/oncotarget.2151","volume":"5","author":"HK Seo","year":"2014","unstructured":"Seo HK, Seo JB, Nam JK, Jeong KC, Shin SP, Kim IH et al. Development of replication-competent adenovirus for bladder cancer by controlling adenovirus E1a and E4 gene expression with the survivin promoter. Oncotarget 2014; 5: 5615\u20135623.","journal-title":"Oncotarget"},{"key":"BFcddis2015128_CR48","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1073\/pnas.95.5.2509","volume":"95","author":"TC He","year":"1998","unstructured":"He TC, Zhou SB, da Costa LT, Yu J, Kinzler KW, Vogelstein B . A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA 1998; 95: 2509\u20132514.","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/cddis2015128.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cddis2015128","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cddis2015128.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T10:01:56Z","timestamp":1672912916000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cddis2015128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,14]]},"references-count":48,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2015,5]]}},"alternative-id":["BFcddis2015128"],"URL":"https:\/\/doi.org\/10.1038\/cddis.2015.128","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,14]]},"assertion":[{"value":"21 November 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}